David Meeker, M.D. Executive Vice President, Therapeutics, Biosurgery & Transplant David Meeker joined Genzyme in 1994. He has served as president of the LSD business unit since 2003, during which time he has led the global launches of Aldurazyme, Fabrazyme and Myozyme. In addition, he oversees the Biosurgery and Transplant business units. Prior to joining Genzyme, Dr. Meeker was director of the Pulmonary Critical Care Fellowship at the Cleveland Clinical Foundation. He was also an assistant professor of medicine at Ohio State University. Dr. Meeker attended Dartmouth College and has an M.D. from the University of Vermont Medical School.